Trust Company of the Ozarks’s Teva Pharmaceuticals TEVA Stock Holding History

Trust Company of the Ozarks’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$2.32M	Sell	41,029 -825	-2%	-$53.5K	0.8%	18
2015 Q2	$2.47M	Sell	41,854 -1,211	-3%	-$74.7K	0.69%	16
2015 Q1	$2.68M	Sell	43,065 -1,615	-4%	-$93.9K	0.71%	13
2014 Q4	$2.57M	Hold	44,680	–	–	0.71%	16
2014 Q3	$2.4M	Sell	44,680 -1,308	-3%	-$69.3K	0.68%	16
2014 Q2	$2.41M	Sell	45,988 -75	-0.2%	-$3.83K	0.65%	18
2014 Q1	$2.43M	Buy	46,063 +1,000	+2%	+$46.2K	0.69%	17
2013 Q4	$1.81M	Buy	45,063 +775	+2%	+$30.5K	0.52%	28
2013 Q3	$1.67M	Buy	44,288 +612	+1%	+$23.9K	0.53%	27
2013 Q2	$1.71M	Buy	+43,676	New	+$1.7M	0.57%	23

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Trust Company of the Ozarks's TEVA Position: Q3 2015 in Review

Trust Company of the Ozarks reduced its Teva Pharmaceuticals (TEVA) stake by 2% in Q3 2015, selling an estimated $53.5K and leaving 41,029 shares worth $2.32M. The position accounts for 0.8% of the portfolio, ranked #18.

Trust Company of the Ozarks first reported a position in TEVA in Q2 2013 and has held it in 10 quarters since. The position peaked at $2.68M in Q1 2015. 824 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

Trust Company of the Ozarks held 41,029 shares of Teva Pharmaceuticals worth $2.32M as of Q3 2015.
Trust Company of the Ozarks sold 825 Teva Pharmaceuticals shares in Q3 2015, an estimated $53.5K.
Teva Pharmaceuticals made up 0.8% of Trust Company of the Ozarks's portfolio in Q3 2015, its #18 holding.
Trust Company of the Ozarks first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
Trust Company of the Ozarks's Teva Pharmaceuticals position peaked at $2.68M in Q1 2015.
824 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on Trust Company of the Ozarks's 13F filing for Q3 2015, filed 4 Nov 2015.